196 related articles for article (PubMed ID: 12673805)
21. Fanconi anemia in Tunisia: high prevalence of group A and identification of new FANCA mutations.
Bouchlaka C; Abdelhak S; Amouri A; Ben Abid H; Hadiji S; Frikha M; Ben Othman T; Amri F; Ayadi H; Hachicha M; Rebaï A; Saad A; Dellagi K;
J Hum Genet; 2003; 48(7):352-61. PubMed ID: 12827451
[TBL] [Abstract][Full Text] [Related]
22. Endocrine profiling in patients with Fanconi anemia, homozygous for a FANCG founder mutation.
Dillon B; Feben C; Segal D; du Plessis J; Reynders D; Wainwright R; Poole J; Krause A
Mol Genet Genomic Med; 2020 Aug; 8(8):e1351. PubMed ID: 32529760
[TBL] [Abstract][Full Text] [Related]
23. Spectrum of FANCA mutations in Italian Fanconi anemia patients: identification of six novel alleles and phenotypic characterization of the S858R variant.
Savino M; Borriello A; D'Apolito M; Criscuolo M; Del Vecchio M; Bianco AM; Di Perna M; Calzone R; Nobili B; Zatterale A; Zelante L; Joenje H; Della Ragione F; Savoia A
Hum Mutat; 2003 Oct; 22(4):338-9. PubMed ID: 12955722
[TBL] [Abstract][Full Text] [Related]
24. Tetratricopeptide-motif-mediated interaction of FANCG with recombination proteins XRCC3 and BRCA2.
Hussain S; Wilson JB; Blom E; Thompson LH; Sung P; Gordon SM; Kupfer GM; Joenje H; Mathew CG; Jones NJ
DNA Repair (Amst); 2006 May; 5(5):629-40. PubMed ID: 16621732
[TBL] [Abstract][Full Text] [Related]
25. The BRCA1-interacting helicase BRIP1 is deficient in Fanconi anemia.
Levran O; Attwooll C; Henry RT; Milton KL; Neveling K; Rio P; Batish SD; Kalb R; Velleuer E; Barral S; Ott J; Petrini J; Schindler D; Hanenberg H; Auerbach AD
Nat Genet; 2005 Sep; 37(9):931-3. PubMed ID: 16116424
[TBL] [Abstract][Full Text] [Related]
26. A cross-linker-sensitive myeloid leukemia cell line from a 2-year-old boy with severe Fanconi anemia and biallelic FANCD1/BRCA2 mutations.
Meyer S; Fergusson WD; Oostra AB; Medhurst AL; Waisfisz Q; de Winter JP; Chen F; Carr TF; Clayton-Smith J; Clancy T; Green M; Barber L; Eden OB; Will AM; Joenje H; Taylor GM
Genes Chromosomes Cancer; 2005 Apr; 42(4):404-15. PubMed ID: 15645491
[TBL] [Abstract][Full Text] [Related]
27. New insights into the Fanconi anemia pathway from an isogenic FancG hamster CHO mutant.
Tebbs RS; Hinz JM; Yamada NA; Wilson JB; Salazar EP; Thomas CB; Jones IM; Jones NJ; Thompson LH
DNA Repair (Amst); 2005 Jan; 4(1):11-22. PubMed ID: 15533833
[TBL] [Abstract][Full Text] [Related]
28. Intermediate DNA repair activity associated with the 322delG allele of the fanconi anemia complementation group C gene.
Donahue SL; Lundberg R; Campbell C
J Mol Biol; 2004 Oct; 342(5):1443-55. PubMed ID: 15364573
[TBL] [Abstract][Full Text] [Related]
29. [Construction of FANCA mutant protein from Fanconi anemia patient and analysis of its function].
Chen F; Zhang KJ; Zuo XL; Zeng XC
Zhonghua Xue Ye Xue Za Zhi; 2007 Nov; 28(11):741-4. PubMed ID: 18457264
[TBL] [Abstract][Full Text] [Related]
30. [Molecular study of Fanconi anemia in Tunisia].
Bouchlaka C; Abdelhak S; Dellagi K;
Tunis Med; 2004 May; 82(5):402-10. PubMed ID: 15453041
[TBL] [Abstract][Full Text] [Related]
31. Fanconi anaemia in black South African patients heterozygous for the FANCG c.637-643delTACCGCC founder mutation.
Wainstein T; Kerr R; Mitchell CL; Madaree S; Essop FB; Vorster E; Wainwright R; Poole J; Krause A
S Afr Med J; 2013 Oct; 103(12 Suppl 1):970-3. PubMed ID: 24300640
[TBL] [Abstract][Full Text] [Related]
32. [FANCA gene mutation analysis in Fanconi anemia patients].
Chen F; Peng GJ; Zhang K; Hu Q; Zhang LQ; Liu AG
Zhonghua Xue Ye Xue Za Zhi; 2005 Oct; 26(10):616-8. PubMed ID: 16532972
[TBL] [Abstract][Full Text] [Related]
33. Fanconi anemia founder mutation in Macedonian patients.
Madjunkova S; Kocheva SA; Plaseska-Karanfilska D
Acta Haematol; 2014; 132(1):15-21. PubMed ID: 24356203
[TBL] [Abstract][Full Text] [Related]
34. [Chart 48: FANCG/XRCC9 (type G Fanconi's anemia)].
Soussi T
Bull Cancer; 2001 Dec; 88(12):1149-50. PubMed ID: 11792607
[No Abstract] [Full Text] [Related]
35. Genetic subtyping of Fanconi anemia by comprehensive mutation screening.
Ameziane N; Errami A; Léveillé F; Fontaine C; de Vries Y; van Spaendonk RM; de Winter JP; Pals G; Joenje H
Hum Mutat; 2008 Jan; 29(1):159-66. PubMed ID: 17924555
[TBL] [Abstract][Full Text] [Related]
36. A rapid method for retrovirus-mediated identification of complementation groups in Fanconi anemia patients.
Chandra S; Levran O; Jurickova I; Maas C; Kapur R; Schindler D; Henry R; Milton K; Batish SD; Cancelas JA; Hanenberg H; Auerbach AD; Williams DA
Mol Ther; 2005 Nov; 12(5):976-84. PubMed ID: 16084127
[TBL] [Abstract][Full Text] [Related]
37. Spectrum of beta-globin gene mutations among thalassemia patients in the West Bank region of Palestine.
Darwish HM; El-Khatib FF; Ayesh S
Hemoglobin; 2005; 29(2):119-32. PubMed ID: 15921164
[TBL] [Abstract][Full Text] [Related]
38. Chemosensitizing tumor cells by targeting the Fanconi anemia pathway with an adenovirus overexpressing dominant-negative FANCA.
Ferrer M; de Winter JP; Mastenbroek DC; Curiel DT; Gerritsen WR; Giaccone G; Kruyt FA
Cancer Gene Ther; 2004 Aug; 11(8):539-46. PubMed ID: 15192709
[TBL] [Abstract][Full Text] [Related]
39. Fanconi anemia protein, FANCG, is a phosphoprotein and is upregulated with FANCA after TNF-alpha treatment.
Futaki M; Watanabe S; Kajigaya S; Liu JM
Biochem Biophys Res Commun; 2001 Feb; 281(2):347-51. PubMed ID: 11181053
[TBL] [Abstract][Full Text] [Related]
40. Diagnosis of Fanconi Anaemia by ionising radiation- or mitomycin C-induced micronuclei.
Francies FZ; Wainwright R; Poole J; De Leeneer K; Coene I; Wieme G; Poirel HA; Brichard B; Vermeulen S; Vral A; Slabbert J; Claes K; Baeyens A
DNA Repair (Amst); 2018 Jan; 61():17-24. PubMed ID: 29154021
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
